The Effect of Adding Pain Relievers to Local Anesthesia Before Preforming Drainage in Peritonsillar Abscess (pta)
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to find if adding oral pain relievers as DYPIRON and TRAMADOL in addition to the local anesthesia injection, can help reducing the pain intensity in patients who diagnosed as Suffering from peritonsillar abscess (PTA)and treated by incision and drainage .
| Condition | Intervention |
|---|---|
|
Peritonsillar Abscess |
Drug: dypiron, tramadol |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | The Efficiency of DYPIRON and TRAMADOL in Addition to Local Anesthesia Prior to Incision and Drainage Procedure in Peritonsillar Abscess |
- the vas scale [ Time Frame: 40 min after giving the oral drugs ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 32 |
| Study Start Date: | November 2011 |
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | November 2011 (Final data collection date for primary outcome measure) |
-
Drug: dypiron, tramadol
Control group: the patient will get local anesthesia injection with Lidocain. After 5 minutes- the DR will preform the incision and drainage of the abscess.
Then the patient will be asked by the vas score, the the pain intensity that he feels.
Intervention group:the patient will get dypiron 4 ml and tramadol 50 mg. after 40 minutes,the patient will get local anesthesia injection with Lidocain. After 5 minutes- the DR will preform the incision and drainage of the abscess.then the patient will be asked by the vas score, the the pain intensity that he feels.
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:patients with PTA in ages 18-65, who agreed to join the research -
Exclusion Criteria:cave to dypiron and/or tramadol, pregnant women, mental illness,soldiers.
-
Contacts and Locations| Contact: shani fisher, RN BA | 046494311 | SUNSHAN2@GMAIL.COM |
| Israel | |
| otolaryngology department, HaEmek mc | Active, not recruiting |
| Afula, Israel | |
| Otolaryngology department, HaEmek MC | Not yet recruiting |
| Afula, Israel | |
| Principal Investigator: Dror Ashkenazy, MD | |
More Information
No publications provided
| Responsible Party: | orolaryngology department, HaEmek MC |
| ClinicalTrials.gov Identifier: | NCT01227200 History of Changes |
| Other Study ID Numbers: | emc100061ctil |
| Study First Received: | October 21, 2010 |
| Last Updated: | October 22, 2010 |
| Health Authority: | Israel: Clalit Health Services |
Additional relevant MeSH terms:
|
Abscess Peritonsillar Abscess Suppuration Infection Inflammation Pathologic Processes Tonsillitis Pharyngitis Pharyngeal Diseases Stomatognathic Diseases Respiratory Tract Infections Respiratory Tract Diseases Otorhinolaryngologic Diseases |
Anesthetics Tramadol Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents Therapeutic Uses Narcotics Analgesics Sensory System Agents Peripheral Nervous System Agents Analgesics, Opioid |
ClinicalTrials.gov processed this record on May 16, 2013